Recursion Pharmaceuticals, Inc - Tech Innovator Profile
Recursion Pharmaceuticals, Inc. is a biotechnology company. Recursion combines experimental biology and bioinformatics with artificial intelligence (AI) in a parallel system to identify treatments quickly and efficiently for any disease which can be modeled at the cellular level.
Scope
The report provides information and insights into Recursions, including -
- Overview of the company and its product offering
- Detailed insight into its business model, company type and headquarter
- Information on funding
- Biography of top management
Reasons to Buy
- Gain insights into Recursions business operations.
- Gain insights into funding and partnerships
- Gain understanding about its technology focus.
Company Overview
Technology Focus Area
Product Overview
Partnerships & Funding
Key Employees
Appendix
Recursion Pharmaceuticals, Inc. - Tech Innovator Profile
Recursion Pharmaceuticals, Inc. - Tech Innovator ProfileRecursion Pharmaceuticals, Inc. is a biotechnology company. Recursion combines experimental biology and bioinformatics with artificial intelligence (AI) in a parallel system to identify treatments
USD 350 View ReportRecursion Pharmaceuticals, Inc. - Tech Innovator Profile
Recursion Pharmaceuticals, Inc. - Tech Innovator ProfileRecursion Pharmaceuticals, Inc. is a biotechnology company. Recursion combines experimental biology and bioinformatics with artificial intelligence (AI) in a parallel system to identify treatments
USD 350 View ReportAntiglaucoma Drugs Global Market Report 2020 Including: 1) By Product Type: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others 2) By Disease Condition Type: Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma 3) By Type: Hospital Prescription drugs, Over-the counter drugs Covering: Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare, Johnson & Johnson
Antiglaucoma Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market.Reasons
USD 4000 View ReportFill The Form For Sample Request